Stallion India Fluorochemicals Limited

Stallion India Fluorochemicals Ltd.: Corrected Link for Earnings Conference Call Audio Recording

Stallion India Fluorochemicals Limited has issued a corrected link for the audio recording of its earnings conference call. The call, held on February 3rd, 2026, discussed the unaudited financial results for the quarter and nine months ended December 31st, 2025. The company apologized for an earlier incorrect link.

Stallion India Fluorochemicals: Audio Recording of Q3 FY26 Earnings Call Now Available

Stallion India Fluorochemicals released the audio recording of its earnings conference call held on February 3rd, 2026. The call focused on the company's unaudited financial results for the quarter and nine months ended December 31st, 2025. The recording is available via a provided Google Drive link.

Stallion India Fluorochemicals Presents Investor Update Highlighting Growth Initiatives and Financial Performance

Stallion India Fluorochemicals shared an investor presentation for the quarter ended December 31, 2025. The company received Environmental Clearance for a 10,000 MT R-32 manufacturing facility in Bhilwara, Rajasthan, expected to commence production by August 2026. This facility aims for ₹250 crore topline in FY26-27 and ₹500-600 crore in FY27-28. The company projects a 30-35% CAGR for the next three years.

Stallion India Fluorochemicals Apologizes for Q3 FY26 Earnings Communication Errors

Stallion India Fluorochemicals apologized for Q3 FY26 earnings communication errors. Q3 FY26 revenue was ₹10,487.90 Lakhs (up 23.17% YoY) and PAT was ₹1,112.69 Lakhs (up 12.42% YoY). 9M FY26 revenue reached ₹32,118.21 Lakhs (up 41.69% YoY) with PAT at ₹3,290.68 Lakhs (up 72.81% YoY). The company targets FY26 revenue of ₹43,000 Lakhs and PAT of ₹4,000 Lakhs.

Stallion India Fluorochemicals Receives In-Principle Approval for ₹364 Crore Rights Issue

Stallion India Fluorochemicals Limited received in-principle approval from NSE and BSE for a rights issue of up to ₹364 Crores. The issue price is [●] per equity share. The approval is conditional upon fulfilling SEBI and exchange regulations. The company must also fix a record date and disclose the issue price.

Stallion India Fluorochemicals to Host Q3 FY26 Earnings Call on Feb 3, 2026

Stallion India Fluorochemicals will hold an earnings call on February 3, 2026, at 4:00 PM IST to discuss Q3 and 9M FY 2025-26 financial results. The call will feature management, including MD & CEO Shazad Rustomji. Registration for the Zoom webinar is required.

Stallion India Fluorochemicals Revises Q3 FY26 Results Press Release Due to Graphical Error

Stallion India Fluorochemicals Limited revised its Q3 FY26 press release due to a graphical error; financial results remain unaffected. For 9M FY26, PAT surged 72.81% YoY to ₹3,290.68 Lakhs on 41.69% revenue growth. The company expects to achieve FY26 revenue of ₹43,000 Lakhs and PAT of ₹4,000 Lakhs.

Stallion India Fluorochemicals Q3 FY26 PAT Surges 12.4% to ₹1,112.69 Lakhs; 9M PAT Up 72.8%

Stallion India Fluorochemicals reported Q3 FY26 PAT of ₹1,112.69 Lakhs (up 12.4%) and 9M FY26 PAT of ₹3,290.68 Lakhs (up 72.8%). Revenue for 9M FY26 rose 41.7% to ₹32,118.21 Lakhs. The company expects to achieve FY26 revenue of ₹43,000 Lakhs and PAT of ₹4,000 Lakhs. Environmental clearance received for an R-32 manufacturing facility, expected by August 2026.

Stallion India Fluorochemicals Q3FY26 Results: Revenue at ₹104.65 Crore, Profit ₹13.21 Crore

Stallion India Fluorochemicals reported unaudited results for Q3FY26. Revenue from operations for the quarter stood at ₹104.65 crore, with a profit after tax of ₹10.82 crore. For the nine months ended December 31, 2025, revenue was ₹305.75 crore and profit after tax was ₹32.86 crore. The company has utilized a significant portion of its IPO proceeds for working capital and capital expenditure on new facilities.

Stallion India Fluorochemicals inks tech tie-up with Portugal's SYS ADVANCE for Helium Systems

Stallion India Fluorochemicals has signed an MoU with Portugal's SYS ADVANCE for Helium Recovery and Liquefaction technology. This tie-up aims to enhance capabilities for space, defense, and industrial applications. The company targets a 3-year revenue CAGR of 30-35%.

Stallion India Fluorochemicals Submits Draft Letter of Offer for Rights Issue

Stallion India Fluorochemicals Limited has submitted its Draft Letter of Offer for a proposed Rights Issue. The issue aims to raise up to ₹364.00 crores by issuing new equity shares at ₹[⦁] each to existing shareholders. The DLOF was filed with NSE and BSE on January 24, 2026. The exact dates for the issue opening and closing are yet to be announced.

Stallion India Fluorochemicals Approves Rights Issue of ₹364 Crore

Stallion India Fluorochemicals' Board approved a Rights Issue of up to ₹364 Crore. The issue will be of Equity Shares with a face value of Rs. 10.00/- each, offered to eligible shareholders on a record date to be determined. A Rights Issue Committee has been formed to manage the process.

Stallion India Fluorochemicals Secures Land for R-32 Facility Expansion

Stallion India Fluorochemicals has secured a 28,650 sq. meter industrial plot from RIICO to support its R-32 manufacturing facility expansion. Construction for the R-32 plant, with a capacity of 10,000 MT per annum, is underway and expected to be commissioned by August 2026. The facility is projected to generate ₹500 crore in annual revenues with 22-24% PAT margins.

Stallion India Fluorochemicals Secures 28,650 Sq. Mtr. Industrial Plot in Rajasthan

Stallion India Fluorochemicals Limited received an allotment letter on November 4, 2025, for an industrial plot of 28,650 sq. meters in Ukhaliya, Rajasthan. This plot will support the expansion and operational requirements of its R-32 Manufacturing Plant, aligning with the company's long-term growth plans.

Stallion India Fluorochemicals submits SEBI Reg 74(5) certificate for Q3 FY26

Stallion India Fluorochemicals Limited has submitted its quarterly certificate under SEBI Regulation 74(5) for the period ending December 31, 2025. The Registrar and Share Transfer Agent confirmed the regulation's non-applicability to member rematerialisation requests during the quarter.

Stallion India Fluorochemicals Closes Trading Window from Jan 1, 2026 for Q3 Results

Stallion India Fluorochemicals Limited will close its trading window from January 1, 2026, until 48 hours after the declaration of Q3 FY26 financial results. PANs of designated persons will be freezed during this period.

Stallion India Fluorochemicals Receives Environmental Clearance for R-32 Plant

Stallion India Fluorochemicals received Environmental Clearance from SEIAA, Rajasthan, for its R-32 Manufacturing Plant. The plant will have a capacity of 10,000 MT per annum for R-32, 46,460 MT per annum for HCl by-product, and 7,500 MT per annum for blended refrigerants. The clearance is valid for 10 years.

Stallion India Reaffirms FY26 Revenue Growth Guidance of 30-35%

Stallion India Fluorochemicals reaffirms FY26 revenue growth guidance of 30-35%. The R-32 project is on schedule for commercial commencement by July 2026 and is expected to generate around ₹500 crore in annual revenue.

Monitoring Agency Report for Quarter Ended 30th September, 2025

Stallion India Fluorochemicals Limited's monitoring agency report for the quarter ended September 30, 2025, identifies deviations in IPO proceeds utilization, including excess spending on issue expenses and commingling of funds.

Stallion India Fluorochemicals Reports Strong Half-Year Growth, Details IPO Fund Utilization

Stallion India Fluorochemicals reported strong half-year financial results with increased revenue and profit, alongside details on the utilization of IPO proceeds for working capital and capital expenditures.

Disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Stallion India: SHAZAD SHERIAR RUSTOMJI increases stake by 3.06% through multiple acquisitions between 29 Oct and 4 Nov 2025, now holding 64.81% of the company.

Promoter infuses ₹45.74 crore in Stallion India for R-32 project

Stallion India Fluorochemicals announced that the promoter will infuse ₹45.74 crore into the company on an interest-free basis for its R-32 manufacturing facility at Bhilwara, Rajasthan.

Stallion India Fluorochemicals starts R-32 facility groundwork in Bhilwara

Stallion India Fluorochemicals begins groundwork for its R-32 manufacturing facility in Bhilwara, Rajasthan, with construction starting 1st November 2025 and commissioning targeted by July 2026.

Stallion India Fluorochemicals Reports Robust Q2 & H1 FY25-26 Results, Details Strategic Expansions

Stallion India Fluorochemicals reported strong Q2 and H1 FY25-26 results with significant revenue and profit growth. The company detailed strategic CapEx plans for R32 manufacturing, HFO, specialty gases, and semiconductor/helium processing, targeting 30-35% CAGR.

Audio Recording of Earnings Call for Q2 & H1 FY26

Stallion India Fluorochemicals Limited announces the availability of the audio recording for the earnings call pertaining to the financial results of Q2 and H1 of FY26.

Stallion India Fluorochemicals Reports Strong Q2 FY26 Unaudited Financial Results

Stallion India Fluorochemicals reported strong unaudited financial results for Q2 FY26 and H1 FY26, with significant growth in total income, PBT, PAT, and EPS compared to the previous year.

Stallion India's Board addresses SEBI non-compliance on Independent Director appointment

Stallion India's Board addressed SEBI's non-compliance notice regarding an Independent Director's age, stating it was a technical lapse and full compliance has been achieved through shareholder approvals.

Stallion India Fluorochemicals revises Q2 FY26 PBT, outlines strong growth and strategic expansion

Stallion India Fluorochemicals revised Q2 FY25-26 PBT to ₹1,524.13 Lakhs and reported strong Q2/H1 financial growth. The company outlined strategic expansion into specialty gases and new facilities, projecting 30-35% CAGR.

Stallion India Fluorochemicals Ltd Announces Investor Presentation

Stallion India Fluorochemicals Ltd announces investor presentation for quarter ended September 30, 2025, highlighting expansion plans, new facilities, and a focus on specialty gases and backward integration to improve profit margins.

Stallion India Fluorochemicals Posts Record Quarterly & Half-Yearly Results; Maintains FY26 Revenue Guidance

Stallion India Fluorochemicals reported record Q2 and H1 FY25-26 results with significant revenue and profit growth, maintaining its full-year revenue guidance of ₹43,000.00 lakhs.

Stallion India Fluorochemicals Board Approves Q2 & H1 FY26 Unaudited Financial Results

Stallion India Fluorochemicals' Board approved unaudited financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Report.

Board approves Unaudited Financial Results for Q2 & H1 ended Sep 30, 2025

Stallion India Fluorochemicals' Board approved unaudited financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Report from auditors.

Stallion India Fluorochemicals to host Q2 & H1 FY25-26 Earnings Call

Stallion India Fluorochemicals to hold an earnings call on October 15, 2025, for Q2 & H1 FY25-26 financial results, with MD & CEO Shazad Rustomji participating.

Certificate under SEBI Regulations 2018 for Quarter Ended 30 Sep 2025

Stallion India Fluorochemicals Limited submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.

STALLION holds 23rd AGM, approves fund-raising, ESOP plan for FY25, and director appointments

Stallion India Fluorochemicals Secures Land for New Bhilwara Manufacturing Plant

Stallion India Fluorochemicals to hold 23rd AGM, seeks approval for ₹500 crore fundraising and ESOP 2025

Stallion India Fluorochemicals Announces Expansion Plans and Strategic Vision

Stallion India Approves Q1 FY26 Results, Fund Raising, ESOP 2025 & AGM on Sept 15

Stallion India Fluorochemicals to Host Q1 FY26 Earnings Call on August 12